Proceedings of Anticancer Research (PAR)
ISSN (Print): 2208-3545
ISSN (Online): 2208-3553
APC: ¥: 2300 CNY
Databases: ✥CNKI, ✥Google scholar,
Publishing Time: Acceptance 2 Months
Aims & Scope
Aims
- To provide an international, peer-reviewed, open-access platform for the rapid publication of high-quality research across all aspects of experimental and clinical oncology.
- To facilitate the exchange of knowledge and collaboration among researchers, clinicians, and professionals worldwide, advancing our understanding and treatment of cancer.
- To bridge the significant gap between experimental oncology research and clinical practice, promoting the translation of findings into improved patient outcomes and cancer care.
- To encourage in-depth exploration and innovative research on emerging trends, therapies, and challenges in cancer biology, prevention, diagnosis, and treatment.
Scope
The journal covers a wide range of topics related to experimental and clinical oncology, including but not limited to:
Core Oncology Domains
- Experimental oncology, including cancer biology, molecular oncology, and tumor immunology
- Clinical oncology, including cancer prevention, diagnosis, treatment, and management
- Cancer genetics, epigenetics, and personalized medicine approaches
- Pharmacology and development of anticancer therapies, including targeted and immunotherapies
- Cancer epidemiology, risk factors, and survivorship research
Accepted Manuscript Types
- High-quality original research articles
- Review articles summarizing key advances in the field
- Case reports of clinical or experimental relevance
- Short communications and research letters